• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    BLACK TITAN CORPORATION APPOINTS CZHANG LIN AS CO-CHIEF EXECUTIVE OFFICER

    11/12/25 8:30:00 AM ET
    $BTTC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $BTTC alert in real time by email

    NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Black Titan Corporation (NASDAQ:BTTC) (the "Company" or "Black Titan") today announced the appointment of Czhang Lin as Co-Chief Executive Officer, further strengthening the Company's leadership team as it accelerates its strategic expansion into the digital asset and blockchain sectors.

    Mr. Lin brings deep expertise in the cryptocurrency and blockchain ecosystem, with a track record of investing in and advising high-growth Web3 projects around the world since 2017. He has collected a vast network over the last 8 years by investing in projects or taking key roles in various funds, that include Binance labs and now currently serves as investment committee for Lbank Labs. Mr. Lin has been instrumental in identifying early-stage opportunities and driving institutional adoption of blockchain technologies.

    In his new role as Co-CEO, Mr. Lin will lead Black Titan's crypto strategy, focusing on strategic investments in digital currencies, direct token acquisitions, blockchain infrastructure, mining operations, and fintech-related mergers and acquisitions. He will work closely with the executive team to position Black Titan at the forefront of the evolving digital asset landscape and unlock long-term value for shareholders.

    "Czhang's leadership and deep experience in digital assets will be instrumental as we execute on our vision to make Black Titan a meaningful player in the global cryptocurrency ecosystem," said Chay W. J., CEO of Black Titan. "His appointment marks the next step in our broader strategy to build a diversified digital asset portfolio and capture opportunities in a rapidly maturing market."

    Mr. Lin added:

    "I am honored to join Black Titan at such a pivotal moment for the industry. With regulatory sentiment shifting and institutional adoption accelerating, we believe the time is right to build a comprehensive digital asset platform that combines strategic investments, operational infrastructure, and innovative technology."

    The appointment follows Black Titan's previously announced plans to seek long-term strategic crypto initiatives and pursue growth opportunities through direct coin acquisitions, and fintech-related transactions.

    Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect Black Titan's current expectations regarding future events, including but not limited to the Company's strategic initiatives in digital assets, blockchain investments, and potential mergers and acquisitions. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's control, that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, changes in market conditions, regulatory developments, volatility in cryptocurrency markets, the Company's ability to execute its business strategy, and other factors described in Black Titan's filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

    Media & Investor Contacts:

    Chay W. J.

    Chief Executive Officer

    (786) 769-7512



    Get the next $BTTC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BTTC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BTTC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BLACK TITAN CORPORATION APPOINTS CZHANG LIN AS CO-CHIEF EXECUTIVE OFFICER

    NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Black Titan Corporation (NASDAQ:BTTC) (the "Company" or "Black Titan") today announced the appointment of Czhang Lin as Co-Chief Executive Officer, further strengthening the Company's leadership team as it accelerates its strategic expansion into the digital asset and blockchain sectors. Mr. Lin brings deep expertise in the cryptocurrency and blockchain ecosystem, with a track record of investing in and advising high-growth Web3 projects around the world since 2017. He has collected a vast network over the last 8 years by investing in projects or taking key roles in various funds, that include Binance labs and now currently serves as investment

    11/12/25 8:30:00 AM ET
    $BTTC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Black Titan Corporation seeks to explore Long-Term Strategic Crypto Initiatives with potential Strategic Investments in Digital Currencies

    NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Black Titan Corporation. (NASDAQ:BTTC) (the "Company" or "Black Titan"), today announced plans to seek long-term strategic crypto initiatives with potential strategic investments in digital currencies. Black Titan is exploring the utilization of a digital currency holding strategy to invest in and capitalize on cryptocurrency opportunities. Black Titan is actively exploring additional investments to expand its portfolio through direct coin acquisitions, mining, and fintech-related mergers and acquisitions. Chay W. J., CEO of Black Titan, remarked, "The approach of leveraging debt, equity, and cash flow to build Crypto holdings has delivered stro

    10/6/25 4:15:00 PM ET
    $BTTC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Titan Pharmaceuticals, Inc. Announces Closing of Merger with Black Titan Corporation

    NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. ("Titan" or "TTNP") today announced the successful closing of its previously announced merger with Black Titan Corporation ("Black Titan") and TalenTec Sdn. Bhd. ("TalenTec"). Following the merger, the combined company's ordinary shares, $0.0001 par value per share, will trade on the Nasdaq stock exchange under the ticker symbol NASDAQ: BTTC. Pursuant to the Merger and Contribution and Share Exchange Agreement dated August 19, 2024, Titan has become a wholly owned subsidiary of Black Titan Corporation, effective as of October 1, 2025. As part of the transaction, each issued and outstanding share of Titan common stock

    10/3/25 5:26:00 PM ET
    $BTTC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BTTC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Black Titan Corporation

    SCHEDULE 13G/A - Black Titan Corp (0002034400) (Subject)

    12/11/25 1:56:32 PM ET
    $BTTC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Black Titan Corporation

    SCHEDULE 13G/A - Black Titan Corp (0002034400) (Subject)

    12/10/25 6:05:01 PM ET
    $BTTC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 20-F filed by Black Titan Corporation

    20-F - Black Titan Corp (0002034400) (Filer)

    11/28/25 5:16:53 PM ET
    $BTTC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BTTC
    Leadership Updates

    Live Leadership Updates

    View All

    BLACK TITAN CORPORATION APPOINTS CZHANG LIN AS CO-CHIEF EXECUTIVE OFFICER

    NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Black Titan Corporation (NASDAQ:BTTC) (the "Company" or "Black Titan") today announced the appointment of Czhang Lin as Co-Chief Executive Officer, further strengthening the Company's leadership team as it accelerates its strategic expansion into the digital asset and blockchain sectors. Mr. Lin brings deep expertise in the cryptocurrency and blockchain ecosystem, with a track record of investing in and advising high-growth Web3 projects around the world since 2017. He has collected a vast network over the last 8 years by investing in projects or taking key roles in various funds, that include Binance labs and now currently serves as investment

    11/12/25 8:30:00 AM ET
    $BTTC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care